Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety study of vildagliptin in patients with type 2 diabetes
jRCT2080220245Phase 3
- Sponsor
- Novartis
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080220245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220245.